Emna Gouider Belhadjali/WFH
Sep 26, 2025, 14:39
Dr. Emna Gouider Belhadjali at 4th International Conference on Hemophilia and Rare Bleeding Disorders
MENA Conference shared a post on LinkedIn:
“How is Glanzmann’s thrombasthenia being addressed in North Africa?
Join Dr. Emna Gouider Belhadjali at the Middle East and North Africa (HEMNET) Session during the 4th International Conference on Hemophilia and Rare Bleeding Disorders, taking place on 11–12 October 2025 at the Grand Hyatt Hotel, Abu Dhabi, UAE, as she presents “Glanzmann in North Africa.””
Stay up to date with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS